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The infiltration of dilute epinephrine solution has been used for many years to provide hemostasis. However, 
epinephrine has adverse cardiovascular effects, such as arrhythmia, pulmonary edema, and even cardiac arrest. We 
have experienced epinephrine-induced cardiovascular crisis, with severe hypertension, tachycardia, and cardiac 
arrest after subcutaneous infiltration of a 2% lidocaine and 1 : 200,000 epinephrine solution in a patient with an 
asymptomatic subarachnoid hemorrhage. We provided successfully advanced cardiac life support in the operating 
room and cardioverted the patient back into a sinus rhythm with no untoward effects. The patient recovered without 
any apparent sequelae after intensive care. (Korean J Anesthesiol 2010; 59: S53-S57)
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    Intracranial diseases such as acute ischemic or hemorrhagic 
stroke, subarachnoid hemorrhage, head trauma, tumor, or 
encephalomeningitis can cause various disorders in the 
cardiovascular system. Among these, subarachnoid hemorrhage 
has been known to be related to electrocardiographic disorder, 
arrhythmia, arrhythmia damage, and neurogenic pulmonary 
edema [1,2]. Epinephrine is widely used in various operations 
to reduce hemorrhaging by constricting the local blood vessels 
and diminishing the systemic toxic effect of local anesthetics. 
However, epinephrine can cause cardiopalmus, headache, 
pallor, and anxiety. Accidental intravenous injection of 
epinephrine or absorption of an excessive amount of it, though 
it has to be locally infiltrated, can cause cerebral hemorrhage, 
ventricular arrhythmia, pulmonary edema, or even cardiac 
arrest. It was reported that even local infiltration of a safe dose 
of epinephrine can cause severe hypertension, ventricular 
arrhythmia, acute pulmonary edema, or cardiac arrest [3,4]. 
The authors have experienced a case of cardiovascular 
crisis immediately followed by cardiovascular collapse after 
injection of locally infiltrated epinephrine into a patient with S54 www.ekja.org
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an asymptomatic subarachnoid hemorrhage for facial nerve 
decompression, and we herein report the case with a related 
literature survey.
Case Report
    A 167 cm, 65 kg, male patient at the age of 27 was observed 
in the neurosurgery department for a linear fracture at the 
temporal bone caused by a motorcycle accident that had 
taken place 11 days before the operation and a tiny amount of 
subarachnoid hemorrhage corresponding to Grade 1 of the 
Hunt and Hess grading system (Fig. 1). During the observation, 
facial nerve paralysis, a complication of the fracture, was 
found and a facial nerve decompression operation was 
planned. Though he had cerebral hemorrhage in the history 
from the traffic accident 3 years before, he was provided with 
no particular treatment and there was no specific cerebral 
hemorrhage finding. The encephalomalacia by the previous 
trauma and subarachnoid hemorrhage by the recent accident 
were found in the neuroimaging. All the findings were normal in 
all the preoperative tests that were carried out in the laboratory, 
including the electrocardiography and the chest radiography.
    Thirty minutes before the patient’s arrival in the operation 
room, an intravenous injection of glycopyrrolate 0.2 mg 
and midazolam 3.0 mg was performed. After arriving at 
the operation room, an electrocardiograph, an automated 
noninvasive blood pressure device, and a pulse oximeter 
were attached to the patient. Before the induction, the blood 
pressure was 115/67 mmHg, the heart rate was 75/min, and 
the oxygen saturation was 99%. The induction was performed 
by an intravenous injection of propofol 120 mg, rocuronium 
50 mg, and fentanyl 50 μg, and endotracheal intubation was 
carried out after sufficient muscular relaxation. After checking 
the continuous positive-end carbon dioxide expiration and the 
uniform breath sound from both sides of the chest, the tube was 
fixed at the proper endotracheal location and the mechanical 
ventilation was initiated with O2 1.5 L/min, N2O 1.5 L/min 
and sevoflurane 2 vol%. After the initiation, the positive end 
expiratory pressure was kept at 33-37 mmHg. When preparing 
the operation, the systolic blood pressure was maintained 
at 100-120 mmHg, the heart rate at 80-90/min, and the 
peripheral oxygen saturation at 100%.
    Twenty-five minutes after the induction, the doctor per-
forming the operation injected 2% lidocaine 4 ml including 
1 : 200,000 epinephrine at the retroauricular temporal lobe 
parts for incision after checking the negative blood aspiration. 
Between 20-30 seconds after the local infiltration, the 
heart rate suddenly increased to 160/min and the measured 
blood pressure was 204/135 mmHg. Then, since ventricular 
arrhythmia was found by the electrocardiograph, injection 
of all the anesthetics and the operation were stopped, 
providing 100% oxygen. Though an intravenous injection of 
lidocaine 100 mg was immediately carried out, the ventricular 
arrhythmia continued. Even after the second intravenous 
injection of lidocaine 100 mg, the arrhythmia continued. The 
peripheral pulse was not enhanced, and the blood pressure 
was not measured. Thus, cardiopulmonary resuscitation 
was immediately performed. Following the defibrillation at 
monophasic 200-300-360 J, the heart rate was turned to the 
sinus tachycardia of 110-120/min and the measured systolic 
blood pressure was 100-110 mmHg. However, pulseless 
ventricular arrhythmia was found again after 2 minutes, and 
defibrillation was performed at monophasic 360 J. After that, 
the heart rate was turned to the sinus tachycardia of 110-120/
min again, and the measured systolic blood pressure was 100-
110 mmHg. Again, a supraventricular tachycardia unresponsive 
to vagal maneuver took place and adenosine 6 mg was injected 
rapidly through the external jugular vein. Though the heart 
rate was turned to the sinus tachycardia, defibrillation at 
monophasic 360 J was conducted since the pulseless ventricular 
arrhythmia was found again after 3 minutes. After that, sinus 
rhythm was recovered and the blood pressure and the heart 
Fig. 1. Brain CT shows subarachnoid 
hemorrhage, right fronto-temporal 
convexity and multi-focal encephalo-
malacia of the left frontal and temporal 
lobes due to old brain contusion (A). 
Also, Linear skull fracture of the left 
temporal bone was detected (B). E: 
encephalomalacia, F: linear skull 
fracture, H: subarachnoid hemorrhage. S55 www.ekja.org
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rate were stabilized at 133/81 mmHg and 98/min, respectively. 
The total duration of the cardiopulmonary resuscitation was 
12 minutes. The arterial blood gas test performed at that 
time showed pH 7.435, PaCO2 33.3 mmHg, PaO2 369 mmHg, 
Bicarbonate 23.1 mmol/L, and SaO2 100%. According to cardiac 
enzyme test, creatine kinase-MB (CK-MB) was increased to 4.2 
ng/ml, and Troponin-I to 1.23 ng/ml.
    After the cardiac rhythm of the patient became normal, 
the assisted respiration was continuously carried out in 
the operation room until the spontaneous respiration was 
recovered. The consciousness and the spontaneous respiration 
were restored about 2 and 1/2 hours after the induction, and 
then, the patient was transported to the intensive care unit 
after extubation of the tracheal tube. The fluid injected in the 
operation room was crystalloid solution 500 ml and colloid 
solution 500 ml, and the urination was 300 ml.
    In the intensive care unit, 100% oxygen 5 L/min was provided 
through a mask. The measured blood pressure was 123/72 
mmHg; the heart rate was 97/min; and the peripheral oxygen 
saturation was 100%. The arterial blood gas test results were pH 
7.379, PaCO2 43.3 mmHg, PaO2 111 mmHg, Bicarbonate 24.5 
mmol/L, and SaO2 98%. Electrocardiography was performed 
due to the finding of a heart enzyme level increase, and the left 
ventricular ejection fraction was 35%, indicating dysfunction 
at the left ventricular which was regarded as the sequel of the 
defibrillation and cardiopulmonary resuscitation. There was no 
abnormal finding in the movement of the myocardium wall. On 
the day of entering the intensive care unit, the blood pressure 
was maintained with dopamine 5 μg/kg/min, but the dopamine 
injection was stopped on the second day in the intensive care 
unit. Since the heart enzyme and electrocardiography findings 
were normal and there was no specific finding in the patient’s 
symptom or the physical examinations from the sixth day 
forward in the intensive care unit, the patient was moved to 
the general ward and was discharged after 2 days without any 
sequel.
Discussion
    For the purpose of improving operative vision, a local infil-
tration of epinephrine is often carried out by mixing it with 
physiological saline or local anesthetic, and a side effect rarely 
takes place with the clinical dose. However, as in this case 
report, there are a few cases where cardiovascular collapse takes 
place by a little amount of epinephrine local infiltration.
    Wanamaker et al. [3] reported the case where severe hyper-
tension and tachycardia took place after the hypodermic injec-
tion of 1% lidocaine 3 ml mixed with 1 : 100,000 epinephrine 
for tympanoplasty, followed by ventricular tachycardia and 
ventricular fibrillation, and thus cardioversion was required. 
Woldorf and Pastore [4] also reported the case where pulmo-
nary edema, as well as severe low blood pressure with the 
systolic blood pressure lower than 30 mmHg and tachycardia, 
took place after the infiltration of 1% lidocaine 5 ml mixed with 
1 : 200,000 epinephrine to the gingivobuccal fold mucosa. In 
our case report, a hypodermic injection of 2% lidocaine 4 ml 
mixed with 1 : 200,000 epinephrine was carried out, dividing 
the total amount into several times, into the part around the 
retroauricular mastoid, as in the case of the first example. 
The total amount of epinephrine used in the quoted cases 
was 30 μg and 25 μg, respectively, and the amount in our case 
was 20 μg. The maximum allowable dose for adults is the 
maximum therapeutic dose of 0.5-1 mg and the minimum 
lethal dose of 4 mg for hypodermic injection, which are a 
little amount compared to the maximum allowed dose of 
7-8 mg [5]. In addition, considering that the maximum safe 
dose of epinephrine can be increased due to the endogenous 
vasoconstriction and the protective effect of lidocaine that is 
jointly used [6], the amount in this case was insufficient to cause 
cardiovascular collapse, even though it is assumed that all the 
injected epinephrine was immediately absorbed in the linear 
fracture at the temporal bone or the vein.
    A few factors were presumed as the causes of the electrocar-
diographic disorder by the tiny amount of epinephrine in this 
case report.
    First, subarachnoid hemorrhage may be one of the factors, 
though there was no abnormal finding in the physical 
examination or other tests except the pain at the fractured part 
in the temporal region. In the acute phase of subarachnoid 
hemorrhage, cardiovascular crisis can take place due to 
an imbalance in neurovegetative control, an increase of 
catecholamine in the circulatory system, and local myocardial 
tissue or hypopituitarism [1,7]. Long QT, P-pulmonale, ST 
segment-elevation and ST segment-depression, inversion 
of T wave, prominent U wave, and temporary pathologic Q 
wave are generated [8], and the generation rate is almost 50-
90%. Such changes are frequently found in the acute phase 
(0-72 hours) and turn to the normal states after a few days. 
However, clinically significant arrhythmias, such as ventricular 
tachycardia and atrial tachyarrhythmia, are also found in 1-4% 
of the patients [7].
    The possibility that epinephrine caused hypersensitization 
in the body cannot be ruled out. Carter et al. [9] measured 
the discharged epinephrine and the metabolites after an 
epinephrine hypodermic injection and reported that the 
detected amount was 2 times more than the expected value. 
They mentioned the possibility of endogenous catecholamine 
hypersensitization by the externally injected catecholamine. 
However, this explanation might be valid only for the clinical 
pattern when hundreds of small quantity epinephrine units are S56 www.ekja.org
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injected.
    On the other hand, the studies that compared the vasocon-
striction effect depending on the ratio of local anesthetic 
revealed that there was no significant clinical difference, 
although a wide range of concentrations were tested from 1 : 
50,000 to 1 : 400,000 [10,11]. If so, the use of a lower concen-
tration of epinephrine for the vasoconstriction effect can be 
helpful in reducing various complications.
    Inhalation anesthetics can also affect the occurrence of 
arrhythmia by a little amount of epinephrine injected from 
outside. However, this can hardly be the cause of the ventricular 
arrhythmia since sevoflurane, which was used in this case 
report, shows a low epinephrine-induced arrhythmia incidence 
rate, although it has a negative myocardial inotropic effect 
similar to that of isoflurane and desflurane [12].
    The patient in this case report undertook the operation on the 
11th day after the injury, after the acute phase, and did not show 
any abnormality in the electrolyte test and electrocardiography 
in the preoperative tests without any past history of heart 
disease. Even though the patient did not have any specific 
symptoms like those, a little amount of subcutaneous infilt-
ration caused the arrhythmia 11 days after the injury. In 
conclusion, it can be assumed that the asymptomatic, but 
definitely existing, subarachnoid hemorrhage might have 
caused the increase of catecholamine and hypopituitarism that 
were not clinically revealed as well. Under such conditions, the 
externally-injected catecholamine caused an overresponse by 
the endogenous catecholamine hypersensitization.
    To prevent the epinephrine-induced cardiovascular crisis, a 
patient’s family and personal history regarding cardiovascular 
diseases, cryptorrhea, and medication should be thoroughly 
investigated before the operation and attention should be paid 
to the ventilation, blood pressure, heart rate, and the heart 
rhythm during the operation.
    The therapy for epinephrine-induced cardiovascular crisis is 
symptomatic and similar to the therapy for pheochromocytoma. 
For the treatment of severe hypertension, α-adrenergic blockers 
such as phentolamine are recommended, and β-adrenergic 
blockers are recommended for the treatment of tachycardia. 
Esmolol, the short acting β1-selective blocker, is preferred 
because it has a short half-life; it can be used by volume 
titration depending on the heart rate; and it can reduce the 
risk of hypertension and coronary spasm due to the excessive 
α-stimulation that is found in nonspecific β-blockers [13]. 
Calcium-channel blockers, such as verapamil and diltiazem, 
are also used for hypertension, tachycardia, and arrhythmia. 
The cardiopulmonary resuscitation algorithm is practiced for 
the treatment of arrhythmia and cardiac arrest. In this case, 
since ventricular arrhythmia was found a few seconds after 
tachycardia and hypertension, lidocaine, which has been used 
for a long time with a less immediate adverse reaction, was 
used, but there was no response. Since the pulseless ventricular 
arrhythmia was found, the defibrillator was prepared and 
cardioversion was tried. For the defibrillation, monophasic 200-
300-360 J, the conventional 3-successive-shock, was used, but 
intravenous injection of amiodarone and biphasic 1 shock are 
recommended in the present cardiopulmonary resuscitation 
guidelines [14]. Amiodarone affects the sodium channel, 
potassium channel, and calcium channel, and it has a blocking 
effect on α and β sympathetic nerve receptors. It is injected 
in ventricular fibrillation or ventricular tachycardia patients 
who are not responsive to cardiopulmonary resuscitation, 
electroshock, or vasoconstrictor by an initial intravenous 
injection of 150 mg for 10 minutes, and the daily maximum 
allowance is 2.2 g. Because the 3 successive shocks can interrupt 
the thoracic compression and inhibit the perfusion pressure 
to the coronary artery, biphasic 1 shock 200 J is recommended 
at present. It should be corrected that we did not follow the 
treatment guidelines revised in 2005, but applied the drugs and 
procedures that were recommended before the revision in this 
case.
    In conclusion, this case shows that cardiovascular crisis, 
such as arrhythmia and cardiac arrest, took place after a small 
amount, clinical volume of epinephrine was injected in a 
healthy patient without any heart disease. As in this case report, 
for the patients who have the potential of hypersensitization to 
externally injected epinephrine due to an intracranial lesion, 
positive monitoring and preparation are required in case of 
cardiovascular crisis, even if there is no abnormal finding in the 
physical examination or the laboratory tests for the operation 
after the acute phase.
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